|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net earnings | |||||
| Adjustments to arrive at net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Impairment of intangible assets | |||||
| Loss on divestitures | |||||
| Share-based compensation | |||||
| Unrealized (gain) loss on investments, net | |||||
| Deferred income taxes | |||||
| Other items | |||||
| Changes in other assets and liabilities | |||||
| Accounts and notes receivable | |||||
| Inventories | |||||
| Accounts payable | |||||
| Other assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Acquisition of and equity investments in businesses, net of cash acquired | |||||
| Proceeds from sale of equity method investment | |||||
| Other investing activities, net | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Debt repayments | |||||
| Proceeds from Revolving Facility | |||||
| Repayments of Revolving Facility | |||||
| Proceeds from issuance of Term Facility | |||||
| Proceeds from issuance of Senior Notes | |||||
| Repayments of debt, net | |||||
| Debt financing costs | |||||
| Dividends paid to ordinary shareholders | |||||
| Proceeds from Stock Options Exercised | |||||
| Repurchase of ordinary shares | |||||
| Other financing activities, net | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents – beginning of period | |||||
| Cash and cash equivalents – end of period | |||||
Loading...